MARLBOROUGH, Mass., Nov. 5, 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will
participate in the 2024 UBS Global Healthcare Conference on
Tuesday, November 12, 2024.
Nick Spadea-Anello, president,
Electrophysiology, and Jon Monson,
senior vice president, Investor Relations, will participate in a
35-minute question-and-answer session with the host analyst at
approximately 7:15 a.m. PT /
10:15 a.m. ET. A live webcast and
replay of the session will be accessible at
htts://investors.bostonscientific.com. The replay will be available
approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical
technologies that improve the health of patients around the world.
As a global medical technology leader for more than 45 years, we
advance science for life by providing a broad range of
high-performance solutions that address unmet patient needs and
reduce the cost of health care. Our portfolio of devices and
therapies helps physicians diagnose and treat complex
cardiovascular, respiratory, digestive, oncological, neurological
and urological diseases and conditions. Learn more at
www.bostonscientific.com and connect on LinkedIn
and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media
Relations
+1 (508)
382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-the-2024-ubs-global-healthcare-conference-302296287.html
SOURCE Boston Scientific Corporation
